Digital Health and Introducing Innovative Technologies in the NHS
|
|
- Ralph Sanders
- 5 years ago
- Views:
Transcription
1 Digital Health and Introducing Innovative Technologies in the NHS 22 September 2015 NATIONAL INFORMATION BOARD #techuk
2 Digital Health and introducing innovative technologies in the NHS 22 September 2015 Exploring the opportunities and challenges for unlocking digital health investment and supporting the uptake of digital health technologies
3 Role of the Office for Life Sciences Office for Life Sciences (OLS) overarching mission: To make the UK the best place in the world to discover, design, manufacture, and adopt 21st Century healthcare and life sciences technologies Generating: maximum health benefit for each 1 spent the wealth to pay for our rising healthcare costs high quality jobs Digital health one of the Department of Health s growth priorities: To create a more productive, digitised NHS and a world-leading digital health industry OLS contribution to create the right policy and business environment to stimulate a thriving digital health industry in the UK and to help facilitate quicker NHS adoption of effective digital health technology through the Accelerated Access Review 3 3
4 Ambition for a digitised health and care system By 2020: - all care records will be digital, real-time and interoperable Pilot NHS app assessment process NHS.UK alpha New innovation prize for digital tools to improve mental health outcomes Test bed collaborations selected Accelerated Access review considers digital health adoption All patients can access own GP electronic record online in full Review of security standards for patient data Guidelines for protection of personal data New consent and opt out model for patients One quarter of all UK smart phone users accessing NHS services and records online We will be paper-free at the point of care in primary, urgent and emergency settings Patients can access a record of all of their health and care interactions Key healthcare professionals will have access to digital skills development All care records including social care will be digital, real time and interoperable 4
5 Ambition for a world leading digital health industry By 2020: - the UK digital health market will increase in value to 3.5bn and digital health employment will rise from 11,000 today 40.0% 35.0% 30.0% 25.0% UK digital health markets growth forecast 35.1% 24.6% 24.0% UK digital health market, % 5% 5% 8% 20.0% 15.0% 10.0% 5.0% 4.4% 13.2% 6.0% 66% 13% 0.0% Telecare Telehealth Applications Wearables Health Analytics Projected Compound Annual Growth Rate (CAGR) Digital Health Systems Applications Telehealth Wearables Health Analytics Telecare Digital Health Systems Source: Deloitte Analysis for the Office for Life Sciences 5
6 Known challenges to digital health adoption Investment in underpinning infrastructure Data standards System and organisational interoperability Multiple buyers and purchasing practices Technical Proprietary systems Budget silos Nascent business models Regulatory pathways Structures & processes in the healthcare system Market & supply Evaluation methods that keep pace with tech time Clinical testing grounds Cultural Procurement rules Public trust in health data and tech Clinical enthusiasm Changes to ways of working Information governance and data sharing Lack of health informatics skills 6
7 Current activity to support the uptake of digital health National Information Board A collaboration of health and care organisations from the NHS, social care, public health, clinical science, central and local government setting the direction for the transition to a paperless health and care system by 2020 Challenges addressed: - Technical (interoperability and data standards) - Cultural (digital leadership and skills of healthcare professionals; public trust; information governance) - Structures & processes (app assessment) 500+ global innovators attended London briefing event 375 Expressions of interest from companies. 39 potential test bed sites 260 selected to brokering events Partnership building TEST BEDS Accelerated Access Review An independent review aiming to speed up access to innovative drugs, devices and digital health treatments for NHS patients Test beds Sites for testing the real world impact of technologies, with a digital element including internet of things, at scale. Matching innovations with the challenges faced by local areas in England. Challenges addressed: - Structures & processes (articulating need for innovation; accelerated development pathways; affordable national funding models; uptake and adoption) Challenges addressed: - Structures & processes (clinical testing grounds) - Cultural (changes to ways of working, clinical enthusiasm) - Technical (system and organisational interoperability) 7
8 NATIONAL INFORMATION BOARD Helen Arthur The work of the National Information Board
9 Digital health in the Accelerated Access Review Tuesday 22 nd September 2015
10 The review aims to accelerate access to innovative drugs, devices, diagnostics and digital products for NHS patients. Good for patients o Opportunity to access novel drugs and treatments more quickly Good for the NHS o o Simplifying and joining up processes Making good, cost-effective, products available to patients more quickly driving potential for better outcomes at the same/lower cost. Affordability will be front and centre of the review. Good for research organisations and charities o Embedding them and their patient populations in the process from the start Good for business o o Simplifying pathways and joining up assets in existing landscape Giving good products earlier access to patients (generating data, demonstrating value) Good for this country o Making us the best place in the world to design, develop and deploy innovative products 10
11 Context: The review is focussing on end-to-end pathways, drawing together four workstreams underpinned by patient views. Three end to end pathways: a Medicines: to include developing/refining future-proofed pathways for genomics and precision medicines (with companion diagnostics). b Medical technologies: to include developing/refining future-proofed pathways for standalone diagnostics. c Digital health: to include designing pathways tailored specifically towards next generation digital products and addressing particular issues e.g. designing technology risk stratification principles and acknowledging data interoperability requirements Addressed via four workstreams, each with an external champion: 1 Articulating need, priorities and principles for innovation Dr Stuart Dollow, Vermilion Affordable Accelerated national funding development models to drive pathways innovation Prof Richard Barker, CASMI Richard Murray, King s Fund Supporting affordable uptake and adoption Rob Webster, NHS Confed Underpinned by patient and user engagement: Patient and user engagement Hilary Newiss, National Voices 11
12 There is a clearly defined decision-making process within the review s governance structure. As the review s independent Chair, Sir Hugh Taylor will make recommendations to relevant ministers (Minister for Life Sciences/SofS Health) Sir Hugh s recommendations will have input from: o Professor Sir John Bell and the review s External Advisory Group; o The review s strategic steering group, Chaired by Una O Brien; o The review s Stakeholder Reference Group o The workstream champions; o The review team, staffed by OLS and DH officials and secondees from key stakeholder organisations; and, o Wider stakeholders. None of these groups have a veto on recommendations made by the review s final report, which will be made by Sir Hugh Taylor. 12
13 Each workstream has a clear purpose and scope, and workstream leads will work closely to ensure that their recommendations focus on joined-up, end-to-end pathways. Workstream 1 will develop a transparent framework for early dialogue and collaboration which drives transformative innovation and supports partnerships from end to end. Scope: Horizon scanning; Identifying patient and NHS needs and sharing with innovators; Early dialogue on value of innovation; Early advice services; Strengthening partnership and collaboration. Workstream 4 aims to accelerate the speed at which clinically and cost effective innovative products are commissioned and get to NHS patients. Scope: Commissioning, adoption and diffusion i.e. from agreement on reimbursement levels to the point at which a product is being used across England; Incentivising decision makers to drive uptake of appropriate innovation, inc. financial incentives; Streamlining routes to market/contracting; Leverage of wider govt/alb initiative. Patient input Workstream 2 aims to streamline regulatory processes and articulate a clear accelerated process for innovative products; or to build a best practice pathway where this does not exist. Scope: Regulatory processes (fast-tracking opportunities); Evidence requirements agreed across stakeholders, inc. for products with small patient populations; Review of Early Access to Medicines Scheme; EU legislation flexibilities, medium term reform. Workstream 3 will propose solutions to integrate or accelerate national reimbursement processes and fund clinically and cost-effective innovation across the pathway. Scope: NICE framework and scope Flexible reimbursement models Tariff Concepts of affordability and value Out of scope: 2014 PPRS, QALY design and threshold
14 Aim of today s workshop What are we trying to achieve? Digital health products are part of the new innovative solutions to which we want to accelerate access, so we need to ensure that the Review s workstreams are sufficiently considering issues relating to digital alongside pharma, med tech and diagnostics. Today s workshop aims to: Ensure the review considers the digital pathway to the same degree as the pharmaceutical pathway. Engage the right stakeholders from across the digital landscape to help us ensure we know what the issues are and can identify solutions (specific to all four workstreams) Begin to find potential solutions to the barriers across all workstreams
15 Scope: The scope for digital health in the review is being bench-marked against the following criteria: 1) Is it an innovation for the NHS and citizens and 2) does it focus on treatment. The work of the National Information Board (NIB) will be of relevance for the review. In particular, NIB workstream 1.2 focusing on providing citizens with access to an endorsed set of NHS and social care apps. DIGITAL HEALTH In scope Out of scope Telecare Telehealthcare Telehealth Wearables mhealth Applications Digitised Health Systems Health Analytics Activity/fall monitoring Medication management * LTC monitoring Video consultation Digitised Med Devices e.g. consumer grade devices and clinical grade devices Medical Apps Website/Social Media Gamification Patient health digital records Hospital held digital records Genomics Precision medicine * Data Analytics Wellness Apps Fitness Apps * where this is directly contributing to treatment e.g. data analytics to interpret data from telehealth monitoring.
16 Overlap with MedTech Stand-alone software including apps Some software applications (apps), which are used on smart phones and computers, can be considered a medical device in their own right if they have a medical purpose. These are called stand-alone software or stand-alone medical devices. This doesn t include software that is part of an existing medical device such as software that controls a CT scanner as it is seen to be part of the device already and not stand-alone in its own right. Medical purpose Software that has a medical purpose could be a medical device. A medical device is defined in the Medical Device Directive (MDD) as software intended by the manufacturer to be used for the purpose of: Diagnosis, prevention, monitoring, treatment or alleviation of disease Diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap Investigation, replacement or modification of the anatomy or of a physiological process Control of conception If a software/app meets the definition of a medical device, it must be regulated by MHRA as a medical device. This is where the digital health strand of the AAR cuts across MedTech.
17 Barriers Initial conversations have already identified some barriers to uptake that are specific to digital health. These fall into one or more of the review s workstreams: Success and failure receive asymmetric rewards successful innovations often don't benefit the NHS innovator much, whereas failure can be a life sentence. This in turn can result in: Procurement that is lengthier than it need be, and favours established suppliers (workstreams 3 and 4) An unwillingness for large companies to promote innovation; (worksteam 4) Clinical risk aversion; (worksteam 4) Much better cross organisation/departmental cooperation is required because: Investment and benefit realisation can take place in different places, so the investing organisation does not automatically receive the rewards of success; Digital health typically requires disruptive process change to deliver efficiencies; Budget silos promote the status quo; Absent an appropriate campaign to persuade, the public still votes for retention of hospital beds.
18 Barriers (cont d) Clinicians resist change, in part because of a fear of loss of control (workstream 4) Although it exists for pharma, there is no agreed realistic means yet of appraising the effectiveness of digital health innovations; What should be the role of NICE? (workstream 3) There is confusion over the regulatory pathway for digital health innovation (workstream 2) The public requires greater assurance of personal data security/privacy (workstream 4 and 5) Outside the Testbed programme, there is a lack of adequate real world testing facilities (workstream 2) There is a lack of: Interoperability across systems (workstream 4) Appropriate data standards (workstream 4) Visibility of what s available (workstream 4)
19 Barriers (cont d) As a disruptive innovation, digital health throws up opportunities that are hard to anticipate well in advance, so some lack of clarity between clinical need and clinical deliverable is unavoidable (workstream 1) Small start-ups are the main source of digital innovations, yet have little experience of selling to the NHS; engaging with these can be difficult (workstreams 3 and 4) Innovations have immature business models, and short track records (workstream 4) There is a lack of provision for iteration and improvement on the design of digital health apps that reach the hands of clinicians. This is partly an effect of procurement processes, but may be a barrier to the adoption of other digital innovations in future; a concern that poor design will make it more hassle than it s worth (workstreams 1 and 4)
20 Accelerated Access Review Table discussions 1 An opportunity to discuss issues faced by digital health innovators selling into the NHS focus on work streams 3 and 4
21 Accelerated Access Review Table discussions 2 Continuing the conversation and discussing the issues faced by digital health innovators - focus on work streams 1 and 2
22 NATIONAL INFORMATION BOARD Q&A #techuk
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationHealth Innovation Manchester
Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing
More information2. Evidence themes and their importance along the development path
1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development
More informationEngaging UK Climate Service Providers a series of workshops in November 2014
Engaging UK Climate Service Providers a series of workshops in November 2014 Belfast, London, Edinburgh and Cardiff Four workshops were held during November 2014 to engage organisations (providers, purveyors
More informationNHS Next Stage Review: Innovation
NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused
More informationSMART PLACES WHAT. WHY. HOW.
SMART PLACES WHAT. WHY. HOW. @adambeckurban @smartcitiesanz We envision a world where digital technology, data, and intelligent design have been harnessed to create smart, sustainable cities with highquality
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationTECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19
TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19 April 2018 Introduction 1. The TEC Board agreed four Strategic Priorities in August 2017 for furthering the development and
More informationABHI Response to the Kennedy short study on Valuing Innovation
ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.
More informationDoing, supporting and using public health research. The Public Health England strategy for research, development and innovation
Doing, supporting and using public health research The Public Health England strategy for research, development and innovation Draft - for consultation only About Public Health England Public Health England
More informationDecember Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationA Science & Innovation Audit for the West Midlands
A Science & Innovation Audit for the West Midlands June 2017 Summary Report Key Findings and Moving Forward 1. Key findings and moving forward 1.1 As the single largest functional economic area in England
More informationConvergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA
EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,
More informationEvidence for Effectiveness
Evidence for Effectiveness Developing a standards framework for digital health innovations Digitally empowering people to manage their health and care October 2018 The issue NHS England programmes Apps
More informationInnovation & health connected. Business plan summary
Innovation & health connected Business plan summary 2017-18 CONTENTS Contents Introduction What do we do? Our five goals Goal 1: Transformation through innovation Goal 2: Economic growth Goal 3: Adoption
More informationNHS and Social Care Innovation and Diffusion Challenges
NHS and Social Care Innovation and Diffusion Challenges NHS and Social Care Innovation and Diffusion Challenges Produced by mhabitat Contents Foreword 4 Introduction 6 Section 1 Mapping support available
More informationTechnology and Innovation in the NHS Highlands and Islands Enterprise
Technology and Innovation in the NHS Highlands and Islands Enterprise Introduction Highlands and Islands Enterprise (HIE) welcomes the opportunity to respond to the Committee s call for views. We recognise
More informationLocal Growth and the changing innovation landscape
Local Growth and the changing innovation landscape Local Growth and Innovation: The Industrial Strategy 11 December 2017 NHS Confederation and Smart Specialisation Hub webinar series Local Growth and Innovation
More informationAdvancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation
Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry
More informationNIHR ROADSHOW FOR MEDTECH SMES
MARTIN HUNT, DIRECTOR FOR INVENTION FOR INNOVATION (i4i) PROGRAMME, NATIONAL INSTITUTE FOR HEALTH RESEARCH Martin is Programme Director for i4i, a translational funding programme. i4i aims to support and
More informationConclusions on the future of information and communication technologies research, innovation and infrastructures
COUNCIL OF THE EUROPEAN UNION Conclusions on the future of information and communication technologies research, innovation and infrastructures 2982nd COMPETITIVESS (Internal market, Industry and Research)
More informationINNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013
INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013 The Challenge Our ambition must be for an NHS defined by its commitment
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationHorizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission
Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The
More informationParkinson s World A transformational project by The Cure Parkinson s Trust
Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication
More informationGreen Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding
Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation Funding Position of the European Brain Council (EBC) Introduction The European Brain
More informationMedicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
More informationHigher Education Contribution to Health Science Innovation
Scottish University of the Year 2017 Higher Education Contribution to Health Science Innovation Professor Sir Pete Downes Principal, University of Dundee Lead Member for Health, Universities Scotland 28
More informationTechnology and Innovation in the NHS Scottish Health Innovations Ltd
Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop
More informationEUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020
EUROPE 2020 17-19 March Brussels, Belgium CALL FOR ABSTRACTS Join Us at the Crossroads of Healthcare I1 Steering Committee Francis Arickx INAMI, Belgium Matthieu Boudes EPF, Belgium Sini Eskola EFPIA,
More informationResponse to the Western Australian Government Sustainable Health Review
Response to the Western Australian Government Sustainable Health Review On behalf of Australia s digital health community, HISA commends this submission to the Sustainable Health Review Panel, and wish
More informationBefore I talk through the strategy itself, I want to tell you more about why
This presentation was given by Dr Annette Bramley, the Healthcare Technologies Theme leader. She thanked Professor Nelson and Professor Taylor for their presentations, and thanked everyone at the meeting
More informationHorizon Scanning. Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper
VTT TECHNICAL RESEARCH CENTRE OF FINLAND LTD Horizon Scanning Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper Principal Scientist in Business, Innovation and Foresight VTT Technical Research
More informationA review of the role and costs of clinical commissioning groups
A picture of the National Audit Office logo Report by the Comptroller and Auditor General NHS England A review of the role and costs of clinical commissioning groups HC 1783 SESSION 2017 2019 18 DECEMBER
More informationFrom Medicine to UX By Dr Gyles Morrison
From Medicine to UX By Dr Gyles Morrison Plan for this evening What is a Clinical UX Designer and what do they do? Group task What are the current challenges for Clinical UX Designers? Break Group task
More informationTable Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...
Table Of Content... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D08 - HAI Europe Newsletter (EN)... 7 D01 - HAI Europe leaflet (EN)... 7 D02 - Briefing Papers and statements
More information25 th Workshop of the EURORDIS Round Table of Companies (ERTC)
25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00
More informationPRIMARY CARE CO-COMMISSIONING
What is Co-Commissioning? Currently, hospital and community services are commissioned by CCGs, while primary care services are commissioned by NHSEngland, and Social Services by Local Authorities. NHSE
More informationGOVERNING BODY MEETING in Public 25 April 2018 Agenda Item 3.2
GOVERNING BODY MEETING in Public 25 April 2018 Paper Title Paper Author(s) Jerry Hawker Accountable Officer NHS Eastern Cheshire CCG The Future of CCG Commissioning in Cheshire Alison Lee Accountable Officer
More informationHTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:
HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually
More informationOpportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive
Opportunities and Challenges in Pharmaceutical Sciences Helen Gordon Chief Executive Challenges we face Drivers for Change in Health Care... and science too Desire for high quality, safe services. The
More informationIoT in Health and Social Care
IoT in Health and Social Care Preserving Privacy: Good Practice Brief NOVEMBER 2017 Produced by Contents Introduction... 3 The DASH Project... 4 Why the Need for Guidelines?... 5 The Guidelines... 6 DASH
More informationDigital Built Britain David Philp Digital Built Britain (DBB): BIM Working Group
Digital Built Britain David Philp Digital Built Britain (DBB): BIM Working Group Digital Construction Week 2017 18 th October 2017 Digital Construction Week 2017 OVERVIEW: DIGITAL BUILT BRITAIN Welcome
More informationImplementation of Systems Medicine across Europe
THE CASyM ROADMAP Implementation of Systems Medicine across Europe A short roadmap guide 0 The road toward Systems Medicine A new paradigm for medical research and practice There has been a data generation
More informationTwenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years
Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationNew methods, how could Norway speed up Health Technology Assessment (HTA) to the benefit of health industry, policy-makers, clinicians and patients?
New methods, how could Norway speed up Health Technology Assessment (HTA) to the benefit of health industry, policy-makers, clinicians and patients? Department director Øyvind Melien Reviews and HTA, Norwegian
More informationNational Coordinated Registry Network (CRN) Think-tank
National Coordinated Registry Network (CRN) Think-tank The Value of Real World Data for Innovation within FDA What can CRNs offer? Murray Sheldon, MD Associate Director for Technology and Innovation FDA/CDRH
More informationHDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018
HDR UK & Digital Innovation Hubs Introduction 22 nd November 2018 Health Data Research UK s vision To create a thriving, high-energy UK-wide network of inter-disciplinary research expertise that will:
More informationBiomedical Innovation Has Science Overtaken the System?
Adaptive Pathways for Transformative Medicinal Products. A New Paradigm with the Enhanced Application of Real-World Evidence? ISPOR 20 th Annual European Congress, Glasgow, Scotland Issue Panel 21, Wednesday,
More informationStrategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use
Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Rosmin Esmail MSc, CHE Director, Knowledge Translation Research, Analytics and Innovation Portfolio Alberta
More informationAdvances and Perspectives in Health Information Standards
Advances and Perspectives in Health Information Standards HL7 Brazil June 14, 2018 W. Ed Hammond. Ph.D., FACMI, FAIMBE, FIMIA, FHL7, FIAHSI Director, Duke Center for Health Informatics Director, Applied
More informationPost : RIS 3 and evaluation
Post 2014-2020: RIS 3 and evaluation Final Conference Györ, 8th November 2011 Luisa Sanches Polcy analyst, innovation European Commission, DG REGIO Thematic Coordination and Innovation 1 Timeline November-December
More informationSUCCESSFULLY IMPLEMENTING TRANSFORMATIONAL TECHNOLOGY IN HOSPITALS AND HEALTH SYSTEMS
SUCCESSFULLY IMPLEMENTING TRANSFORMATIONAL TECHNOLOGY IN HOSPITALS AND HEALTH SYSTEMS Glenn E. Pearson, FACHE Principal, Pearson Health Tech Insights, LLC Georgia HFMA/Georgia HIMSS August 2, 2017 Outline
More information13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer
13 December 2007 A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer Project Team Leela Barham Michelle Ng NERA Economic Consulting 15 Stratford Place London W1C 1BE United Kingdom Tel:
More informationHelping your business grow in the UK health system
Helping your business grow in the UK health system OVERVIEW PROVIDING INSIGHT AND HELPING YOU DELIVER INNOVATIVE PRODUCTS AND SERVICES TO THE NHS AND BEYOND. The health system is a complex and uncertain
More informationWater, Energy and Environment in the scope of the Circular Economy
Water, Energy and Environment in the scope of the Circular Economy Maria da Graça Carvalho 11th SDEWES Conference Lisbon 2016 Contents of the Presentation 1. The Circular Economy 2. The Horizon 2020 Program
More informationCommission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( )
Commission proposal for Horizon Europe THE NEXT EU RESEARCH & INNOVATION PROGRAMME (2021 2027) #HorizonEU Maria da Graça Carvalho Coimbra Group High Level Seminar 6-7 December 2018, San Servolo Research
More informationEnvironmental technology diffusion in developing countries
03/05/2013 Environmental technology diffusion in developing countries The roles of different actors in the transition to a sustainable society Saskia Manshoven Study commissioned by the European Commission,
More informationGetting the evidence: Using research in policy making
Getting the evidence: Using research in policy making REPORT BY THE COMPTROLLER AND AUDITOR GENERAL HC 586-I Session 2002-2003: 16 April 2003 LONDON: The Stationery Office 14.00 Two volumes not to be sold
More informationImpact Case Study Template. Guidance Document
Guidance Document I. Introduction The College of Arts, Celtic Studies and Social Sciences (CACSSS) at UCC has an excellent record in fostering and sustaining high quality research at the forefront of international
More informationIMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters!
IMI Revolutionising Europe s Pharmaceutical Industry IMI Matters! Session in the Framework of the Event Joint Technology Initiatives Innovation in Action 4 6 October 2011 European Parliament Brussels Programme
More informationHealth & Wellbeing Best Practice & Innovation Board. NHS Social Care & Business Workstream. Recommendations on Health and Wealth in Wales
Health & Wellbeing Best Practice & Innovation Board NHS Social Care & Business Workstream - Recommendations on Health and Wealth in Wales Title Recommendations on Health and Wealth in Wales Date October
More informationDenmark as a digital frontrunner
Denmark as a digital frontrunner Recommendations for the government from the Digital Growth Panel May 2017 Digital Growth Panel Summary Vision: Denmark as a digital frontrunner Denmark and the rest of
More informationCatapult Network Summary
Catapult Network Summary 2017 TURNING RESEARCH AND INNOVATION INTO GROWTH Economic impact through turning opportunities into real-world applications The UK s Catapults harness world-class strengths in
More informationCommission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( )
Commission proposal for Horizon Europe THE NEXT EU RESEARCH & INNOVATION PROGRAMME (2021 2027) #HorizonEU Feilim O'Connor - DG ENER, Unit C.2 ETIP SNET Workshops 19/09/2018 Research and Innovation Commission
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationThe Industrial Strategy Challenge Fund
The Industrial Strategy Challenge Fund Mike Biddle Programme Director Industrial Strategy Challenge Fund @Mike_Biddle Harwell - 28 th November 2017 (v4) [Official] Overview 1. Industrial Strategy & the
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 9 December 2008 (16.12) (OR. fr) 16767/08 RECH 410 COMPET 550
COUNCIL OF THE EUROPEAN UNION Brussels, 9 December 2008 (16.12) (OR. fr) 16767/08 RECH 410 COMPET 550 OUTCOME OF PROCEEDINGS of: Competitiveness Council on 1 and 2 December 2008 No. prev. doc. 16012/08
More informationCommission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( )
Commission proposal for Horizon Europe THE NEXT EU RESEARCH & INNOVATION PROGRAMME (2021 2027) #HorizonEU Jürgen Tiedje SPIRE PPP Brokerage Event 14 June 2018 Research and Innovation Horizon Europe is
More informationAndalusian Agency for Health Technology Assessment (AETSA)
Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction
More informationScience for Policy. Impact of Social Sciences & Humanities. David Mair (chair) Antti Pelkonen Mihiri Seneviratne. Gemyse 1,
Impact of Social Sciences & Humanities Gemyse 1, 11.30-12.45 4-5 October 2018, Copenhagen Science for Policy David Mair (chair) Antti Pelkonen Mihiri Seneviratne Impact of Social Sciences & Humanities
More informationWelcome to the future of energy
Welcome to the future of energy Sustainable Innovation Jobs The Energy Systems Catapult - why now? Our energy system is radically changing. The challenges of decarbonisation, an ageing infrastructure and
More informationSocietal engagement in Horizon 2020
Societal engagement in Horizon 2020 19 June 2017 Brussels Colombe WARIN European Commission Research Executive Agency B5 - Spreading Excellence, Widening Participation, Science with and for Society Content
More informationResearch Infrastructures and Innovation
Research Infrastructures and Innovation Octavi Quintana Principal Adviser European Commission DG Research & Innovation The presentation shall neither be binding nor construed as constituting commitment
More informationBrief presentation of the results Ioana ISPAS ERA NET COFUND Expert Group
Brief presentation of the results Ioana ISPAS ERA NET COFUND Expert Group Mandate of the Expert Group Methodology and basic figures for ERA-NET Cofund Efficiency of ERA-NET Cofund Motivations and benefits
More informationIndustrial Strategy Green Paper Response from The Institute of Cancer Research, London
Industrial Strategy Green Paper Response from The Institute of Cancer Research, London March 2017 The Institute of Cancer Research (ICR) is one of the world s most influential cancer research organisations
More informationCatapult Network. Launching your ideas with the UK s new centres for innovation
Catapult Network Launching your ideas with the UK s new centres for innovation The vision What is a Catapult? Hundreds of thousands of businesses in the UK are hungry for growth and capable of bringing
More informationTransforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value
CADTH 2018 2021 STRATEGIC PLAN Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value Health care costs an estimated $242 billion annually
More informationStrategic Plan Public engagement with research
Strategic Plan 2017 2020 Public engagement with research Introduction Public engagement with research (PER) is more important than ever, as the value of these activities to research and the public is being
More informationCCG 360 o stakeholder survey 2017/18
CCG 360 o stakeholder survey 2017/18 Case studies of high performing and improved CCGs 1 Contents 1 Background and key themes 2 3 4 5 6 East and North Hertfordshire CCG: Building on a strong internal foundation
More informationWFEO STANDING COMMITTEE ON ENGINEERING FOR INNOVATIVE TECHNOLOGY (WFEO-CEIT) STRATEGIC PLAN ( )
WFEO STANDING COMMITTEE ON ENGINEERING FOR INNOVATIVE TECHNOLOGY (WFEO-CEIT) STRATEGIC PLAN (2016-2019) Hosted by The China Association for Science and Technology March, 2016 WFEO-CEIT STRATEGIC PLAN (2016-2019)
More informationHealth Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities
Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities Aleksandra Torbica, Carlo Federici, Rosanna Tarricone Centre for Research on Health and
More informationDraft executive summaries to target groups on industrial energy efficiency and material substitution in carbonintensive
Technology Executive Committee 29 August 2017 Fifteenth meeting Bonn, Germany, 12 15 September 2017 Draft executive summaries to target groups on industrial energy efficiency and material substitution
More informationWG/STAIR. Knut Blind, STAIR Chairman
WG/STAIR Title: Source: The Operationalisation of the Integrated Approach: Submission of STAIR to the Consultation of the Green Paper From Challenges to Opportunities: Towards a Common Strategic Framework
More informationIndustrial Innovation Information Days Brussels 3-4 October 2017
Industrial Innovation Information Days Brussels 3-4 October 2017 NMBP Programme Parallel Sessions OPEN INNOVATION TEST BEDS Calls 2018/2019 Helene CHRAYE, HoU Unit D3 DG Research & Innovation A joint presentation
More informationEuropean Network for Health Technology Assessment (EUnetHTA) Joint Action 3
European Network for Health Technology Assessment (EUnetHTA) Joint Action 3 Zoe Garrett, Senior Technical Adviser Lead WP7 National Implementation and Impact National Institute for Health and Care Excellence
More informationClimate Change Innovation and Technology Framework 2017
Climate Change Innovation and Technology Framework 2017 Advancing Alberta s environmental performance and diversification through investments in innovation and technology Table of Contents 2 Message from
More informationInnovation in HTA: What is the additional value?
Innovation in HTA: What is the additional value? Stirling Bryan Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute School of Population & Public Health, UBC My co-authors
More informationA Harmonised Regulatory Framework for Supporting Single European Electronic Market: Achievements and Perspectives
A Harmonised Regulatory Framework for Supporting Single European Electronic Market: Achievements and Perspectives Irina NEAGA, Tarek HASSAN, Chris CARTER Loughborough University, Loughborough, Leicestershire,
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
EUROPEAN COMMISSION Brussels, 9.9.2011 COM(2011) 548 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
More informationInnovative public procurement case Finland
Innovative public procurement case Finland 14.9.2009 Petri Lehto Ministry of Employment and the Economy Innovation department / Demand-based Innovations (www.tem.fi/inno) Finland s Innovation strategy
More informationCompliance for Eucomed: The Medical Technology Industry s s Perspective
Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big
More informationI. Introduction. Cover note. A. Mandate. B. Scope of the note. Technology Executive Committee. Fifteenth meeting. Bonn, Germany, September 2017
Technology Executive Committee 31 August 2017 Fifteenth meeting Bonn, Germany, 12 15 September 2017 Draft TEC and CTCN inputs to the forty-seventh session of the Subsidiary Body for Scientific and Technological
More informationGlobal strategy and plan of action on public health, innovation and intellectual property
SIXTY-FIRST WORLD HEALTH ASSEMBLY WHA61.21 Agenda item 11.6 24 May 2008 Global strategy and plan of action on public health, innovation and intellectual property The Sixty-first World Health Assembly,
More informationPersonal Medical Services (PMS) Contract Review Update
Personal Medical Services (PMS) Contract Review Update 1. Introduction NHS England commenced the Personal Medical Services (PMS) Review process across the North West London (NWL) Collaboration of CCGs
More informationPriorities for medical research in the UK
Priorities for medical research in the UK Sir Leszek Borysiewicz Medical Research Council The Foundation for Science and Technology, 20 May 2009 MRC mission Encourage and support high-quality research
More informationWandsworth CCG Register of Procurement Decisions 2018/19
Wandsworth CCG Register of Procurement Decisions /19 1 MRI Diagnostic Services. Diagnostic Healthcare Epsom and St Helier University Hospitals Mediscan BMI Activity and Cost Basis, 3 years, 1st June AQP
More informationAn Introduction to the UK Leisure Framework.
An Introduction to the UK Leisure Framework gareth@designanimal.co.uk The Start of the Journey Way back in 2008, Denbighshire County Council s leisure service was in a very different place Very poor Wales
More informationElements of a global strategy and plan of action
INTERGOVERNMENTAL WORKING GROUP A/PHI/IGWG/1/5 ON PUBLIC HEALTH, INNOVATION AND 8 December 2006 INTELLECTUAL PROPERTY Agenda item 2.3 Elements of a global strategy and plan of action Progress to date in
More information